Your browser doesn't support javascript.
loading
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
Jung, Seungyoun; Allen, Naomi; Arslan, Alan A; Baglietto, Laura; Brinton, Louise A; Egleston, Brian L; Falk, Roni; Fortner, Renée T; Helzlsouer, Kathy J; Idahl, Annika; Kaaks, Rudolph; Lundin, Eva; Merritt, Melissa; Onland-Moret, Charlotte; Rinaldi, Sabina; Sánchez, María-José; Sieri, Sabina; Schock, Helena; Shu, Xiao-Ou; Sluss, Patrick M; Staats, Paul N; Travis, Ruth C; Tjønneland, Anne; Trichopoulou, Antonia; Tworoger, Shelley; Visvanathan, Kala; Krogh, Vittorio; Weiderpass, Elisabete; Zeleniuch-Jacquotte, Anne; Zheng, Wei; Dorgan, Joanne F.
Afiliação
  • Jung S; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.
  • Allen N; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Arslan AA; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York; Departments of Population Health and Environmental Medicine and Perlmuttr Cancer Center, New York University School of Medicine, New York, New York.
  • Baglietto L; Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Egleston BL; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Falk R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Cancer, Heidelberg, Germany.
  • Helzlsouer KJ; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Idahl A; Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Cancer, Heidelberg, Germany.
  • Lundin E; Department of Medical Biosciences, Pathology, and Public Health and Clinical Medicine: Nutritional Research, Umeå University, Umeå, Sweden.
  • Merritt M; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Onland-Moret C; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Rinaldi S; International Agency for Research on Cancer, Lyon, France.
  • Sánchez MJ; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs, GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Sieri S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Schock H; Division of Cancer Epidemiology, German Cancer Research Cancer, Heidelberg, Germany.
  • Shu XO; Department of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Sluss PM; Department of Pathology, Harvard Medical School, Boston, Massachusetts.
  • Staats PN; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Travis RC; Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
  • Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Trichopoulou A; Hellenic Health Foundation, Athens, Greece; World Health Organization Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Tworoger S; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Baltimore, Maryland; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Visvanathan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Krogh V; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Weiderpass E; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, K
  • Zeleniuch-Jacquotte A; Departments of Population Health and Environmental Medicine and Perlmuttr Cancer Center, New York University School of Medicine, New York, New York.
  • Zheng W; Department of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Dorgan JF; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: jdorgan@som.umaryland.edu.
Fertil Steril ; 107(4): 1012-1022.e2, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28366409
OBJECTIVE: To identify reproductive, lifestyle, hormonal, and other correlates of circulating antimüllerian hormone (AMH) concentrations in mostly late premenopausal women. DESIGN: Cross-sectional study. SETTING: Not applicable. PATIENT(S): A total of 671 premenopausal women not known to have cancer. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates. RESULT(S): Older women had significantly lower AMH concentrations (≥40 [n = 444] vs. <35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (<12 [n = 96] vs. ≥14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection). CONCLUSION(S): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Menopausa / Hormônio Antimülleriano / Reserva Ovariana / Estilo de Vida Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do norte / Asia / Europa Idioma: En Revista: Fertil Steril Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Menopausa / Hormônio Antimülleriano / Reserva Ovariana / Estilo de Vida Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do norte / Asia / Europa Idioma: En Revista: Fertil Steril Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos